Insiders Sanofi Wiener Boerse

Equities

End-of-day quote Wiener Boerse Other stock markets 18:00:00 2024-06-26 EDT			5-day change	1st Jan Change
90.1 ^EUR	-0.76%		+2.24%	+0.68%

06-27	CAC40: caution prevails ahead of crucial deadlines	CF
06-27	CAC40: consolidates solo, OAT/Bund spread widens to 81Pb	CF

Sanofi: new Director of Group Corporate Affairs	06-21	CF
Sanofi Appoints Audrey Duval Derveloy as Executive Vice President, Global Head of Corporate Affairs and Member of its Executive Committee, Effective July 1, 2024	06-21	CI
Jasper Therapeutics, Inc. Announces Board Changes	06-19	CI
Ipsen Hires New Chief Corporate Affairs Officer	06-06	MT
CRISPR Therapeutics Names Naimish Patel as Chief Medical Officer; Promotes Julianne Bruno to Chief Operating Officer	05-23	MT
Novavax Surges on $1.2 Billion Sanofi Vaccine Deal	05-10	MT
Sanofi Announces Board and Committee Appointments	04-30	CI
Smith & Nephew CFO designate John Rogers to start next week	03-28	AN
Dyne Therapeutics President, CEO Joshua Brumm Resigns, John Cox Named Successor; Shares Drop 7% Pre-Bell	03-25	MT
Cynata Therapeutics Names Chief Business Officer; Shares Plunge 14%	02-28	MT
Sanofi appoints Smith & Nephew CFO Nesmes to board	02-23	AN
Sanofi Proposes Appointment of New Independent Directors	02-23	DJ
Sanofi: three nominations for the Board of Directors	02-23	CF
Sanofi Announces Board Resignations	02-22	CI
Sanofi's Q4 Non-GAAP Earnings Fall While Net Sales Rise; Names Francois-Xavier Roger CFO	02-01	MT
Sanofi: new CFO in early April	02-01	CF
Sanofi Appoints Nestlé CFO to Same Role	02-01	MT
Sanofi Announces Executive Changes, Effective April 1, 2024	02-01	CI
Sanofi confirms it expects a decline in business EPS in 2024	02-01	RE
Sanofi Appoints Brian Foard as Head of Specialty Care Global Business Unit and Member of Executive Committee	01-09	CI